Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital
- PMID: 31012990
- DOI: 10.1111/bju.14745
Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital
Abstract
Objectives: To determine the prevalence of extended-spectrum β-lactamase (ESBL) in patients undergoing transrectal prostate biopsy, to assess the incidence of postoperative sepsis, to correlate the development of sepsis with the presence of preoperative ESBL on rectal swabs, and to assess the adequacy of prophylactic antibiotic guidelines in the context of local ESBL prevalence.
Methods: Patients undergoing transrectal ultrasonography (TRUS)-guided biopsy at the Royal Melbourne Hospital between January 2012 and July 2016 had rectal swabs taken immediately prior to TRUS with specific cultures to identify the presence of ESBL. Patients were given a prophylactic antibiotic, 500 mg oral ciprofloxacin, 1 h before the TRUS procedure. Data were collected prospectively, with retrospective review of all readmitted patient files and audit data to ensure complete capture of events.
Results: A total of 387 TRUS-guided biopsy procedures were performed. Rectal swabs were correctly collected in 352 patients (91%). The median patient age was 65 years. In all, 25 (7%) ESBL-positive swabs were identified. Most ESBL were Escherichia coli. Half (50%) of ESBL were resistant to ciprofloxacin and all were sensitive to meropenem. A small increase in ESBL prevalence over time was not significant (R2 = 0.35). Four patients (1.1%) were readmitted with sepsis; ESBL Pseudomonas had previously grown in one patient, but sepsis was attributable to non-ESBL E. coli. In one of the readmitted patients ESBL E. coli was present, but this patient did not have ESBL preoperatively. There were no deaths or high-dependency/intensive care unit admissions.
Conclusions: This study represents the largest Australian series to investigate ESBL prevalence, and reveals a rate lower than that of many other nations. Our sepsis rate is lower than many international series, perhaps because of our low ESBL rate and strict antibiotic prophylaxis. Preoperative swab results did not predict postoperative sepsis, and the process was therefore not useful for guiding antibiotic therapy. In this patient population, TRUS biopsy, with ciprofloxacin prophylaxis, remains a safe option for diagnostic prostate biopsy.
Keywords: #PCSM; #ProstateCancer; Antibiotic prophylaxis; Biopsy; Drug resistance; Prostatic neoplasms; Sepsis; microbial; needle.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.
Similar articles
-
Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.Int J Urol. 2017 Apr;24(4):295-300. doi: 10.1111/iju.13308. Epub 2017 Feb 21. Int J Urol. 2017. PMID: 28222483
-
Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.BJU Int. 2015 Jul;116(1):131-4. doi: 10.1111/bju.12865. Epub 2015 Mar 25. BJU Int. 2015. PMID: 25079680
-
Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?BJU Int. 2014 Sep;114(3):384-8. doi: 10.1111/bju.12536. Epub 2014 Feb 19. BJU Int. 2014. PMID: 24612341 Review.
-
Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli.Clin Infect Dis. 2013 Jul;57(2):267-74. doi: 10.1093/cid/cit193. Epub 2013 Mar 26. Clin Infect Dis. 2013. PMID: 23532481 Review.
-
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.BJU Int. 2013 May;111(6):946-53. doi: 10.1111/j.1464-410X.2012.11637.x. Epub 2013 Mar 6. BJU Int. 2013. PMID: 23464844 Clinical Trial.
Cited by
-
Colonisation with Extended-Spectrum Cephalosporin-Resistant Enterobacterales and Infection Risk in Surgical Patients: A Systematic Review and Meta-analysis.Infect Dis Ther. 2023 Feb;12(2):623-636. doi: 10.1007/s40121-022-00756-z. Epub 2023 Jan 12. Infect Dis Ther. 2023. PMID: 36633819 Free PMC article.
-
Occurrence and significance of fluoroquinolone-resistant and ESBL-producing Escherichia coli and Klebsiella pneumoniae complex of the rectal flora in Ghanaian patients undergoing prostate biopsy.JAC Antimicrob Resist. 2022 Nov 5;4(6):dlac113. doi: 10.1093/jacamr/dlac113. eCollection 2022 Dec. JAC Antimicrob Resist. 2022. PMID: 36349243 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical